1.
|
14 p, 1.5 MB |
European LeukemiaNet 2017 risk stratification for acute myeloid leukemia : validation in a risk-adapted protocol
/
Bataller, Alex (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Garrido, Ana (Institut d'Investigació Biomèdica Sant Pau) ;
Guijarro, Francesca (Hospital Clínic i Provincial de Barcelona) ;
Oñate, Guadalupe (Institut d'Investigació Biomèdica Sant Pau) ;
Diaz-Beyá, Marina (Hospital Clínic i Provincial de Barcelona) ;
Arnan, Montserrat (Institut Català d'Oncologia) ;
Tormo, Mar (Institut Català d'Oncologia) ;
Vives, Susana (Institut Català d'Oncologia) ;
de Llano, María Paz Queipo (Hospital Virgen de la Victoria (Málaga)) ;
Coll, Rosa (Institut Català d'Oncologia) ;
Gallardo, David (Institut Català d'Oncologia) ;
Vall-Llovera, Ferran (Mútua de Terrassa) ;
Escoda, Lourdes (Institut Català d'Oncologia) ;
Garcia-Guiñon, Antonio (Hospital Arnau de Vilanova (Lleida, Catalunya)) ;
Salamero, Olga (Hospital del Mar (Barcelona) ¡) ;
Sampol, Antònia (Hospital Universitari Son Espases (Palma de Mallorca, Balears)) ;
Merchan, Brayan M. (Hospital del Mar (Barcelona)) ;
Bargay, Joan (Hospital Universitari Son Llàtzer (Palma de Mallorca, Balears)) ;
Castaño-Díez, Sandra (Hospital Clínic i Provincial de Barcelona) ;
Esteban, Daniel (Hospital Clínic i Provincial de Barcelona) ;
Oliver-Caldés, Aina (Hospital Clínic i Provincial de Barcelona) ;
Rivero, Andrea (Hospital Clínic i Provincial de Barcelona) ;
Mozas, Pablo (Hospital Clínic i Provincial de Barcelona) ;
López-Guerra, Mònica (Centro de Investigación Biomédica en Red en Cancer) ;
Pratcorona, Marta (Institut d'Investigació Biomèdica Sant Pau) ;
Zamora, Lurdes (Institut Català d'Oncologia) ;
Costa, Dolors (Centro de Investigación Biomédica en Red en Cancer) ;
Rozman, Maria (Hospital Clínic i Provincial de Barcelona) ;
Nomdedeu, Josep (Institut d'Investigació Biomèdica Sant Pau) ;
Colomer, Dolors (Centro de Investigación Biomédica en Red en Cancer) ;
Brunet, Salut (Institut d'Investigació Biomèdica Sant Pau) ;
Sierra, Jorge (Institut d'Investigació Biomèdica Sant Pau) ;
Esteve Reyner, Jordi (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Universitat Autònoma de Barcelona
The 2017 European LeukemiaNet (ELN 2017) guidelines for the diagnosis and management of acute myeloid leukemia (AML) have become fundamental guidelines to assess the prognosis and postremission therapy of patients. [...]
2022 - 10.1182/bloodadvances.2021005585
Blood advances, Vol. 6 (february 2022) , p. 1193-1206
|
|
2.
|
10 p, 1.6 MB |
Association of cortical microstructure with amyloid-β and tau : impact on cognitive decline, neurodegeneration, and clinical progression in older adults
/
Rodriguez-Vieitez, Elena (Karolinska Institutet (Estocolm, Suècia)) ;
Montal, Victor (Institut d'Investigació Biomèdica Sant Pau) ;
Sepulcre, Jorge (Gordon Center for Medical Imaging) ;
Lois, Cristina (Gordon Center for Medical Imaging) ;
Hanseeuw, Bernard (Université Catholique de Louvain) ;
Vilaplana, Eduard (Institut d'Investigació Biomèdica Sant Pau) ;
Schultz, Aaron P. (Athinoula A. Martinos Center for Biomedical Imaging) ;
Properzi, Michael J. (Harvard Medical School) ;
Scott, Matthew R. (Athinoula A. Martinos Center for Biomedical Imaging) ;
Amariglio, Rebecca (Brigham and Women's Hospital (Boston, Estats Units d'Amèrica)) ;
Papp, Kathryn V. (Brigham and Women's Hospital (Boston, Estats Units d'Amèrica)) ;
Marshall, Gad A. (Brigham and Women's Hospital (Boston, Estats Units d'Amèrica)) ;
Fortea, Juan (Institut d'Investigació Biomèdica Sant Pau) ;
Johnson, Keith A. (Gordon Center for Medical Imaging) ;
Sperling, Reisa A. (Brigham and Women's Hospital (Boston, Estats Units d'Amèrica)) ;
Vannini, Patrizia (Brigham and Women's Hospital (Boston, Estats Units d'Amèrica)) ;
Universitat Autònoma de Barcelona
Noninvasive biomarkers of early neuronal injury may help identify cognitively normal individuals at risk of developing Alzheimer's disease (AD). A recent diffusion-weighted imaging (DWI) method allows assessing cortical microstructure via cortical mean diffusivity (cMD), suggested to be more sensitive than macrostructural neurodegeneration. [...]
2021 - 10.1038/s41380-021-01290-z
Molecular Psychiatry, Vol. 26 (september 2021) , p. 7813-7822
|
|
3.
|
1 p, 358.6 KB |
Author Correction : Persons with first episode psychosis have distinct profiles of social cognition and metacognition
/
Ferrer-Quintero, Marta (Investigación Biomédica en Red de Salud Mental (CIBERSAM), Barcelona, Spain) ;
Fernández Martínez, Daniel (Universitat Politècnica de Catalunya) ;
López-Carrilero, R. (Fundació Privada per a la Recerca i la Docència Sant Joan de Déu, Esplugues de Llobregat) ;
Birulés, I. (Universitat de Barcelona) ;
Barajas Vélez, Ana (Centre d'Higiene Mental Les Corts) ;
Lorente-Rovira, E. (Hospital Clínic Universitari (València)) ;
Díaz-Cutraro, L. (S Parc Sanitari Sant Joan de Déu) ;
Verdaguer, M. (Parc Sanitari Sant Joan de Déu) ;
García-Mieres, H. (Parc Sanitari Sant Joan de Déu) ;
Sevilla-Llewellyn-Jones, J. (Hospital Clínico San Carlos (Madrid)) ;
Gutiérrez-Zotes, A. (Universitat Rovira i Virgili) ;
Grasa-Bello, Eva (Institut d'Investigació Biomèdica Sant Pau) ;
Pousa, Esther (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Huerta-Ramos, E. (Centro de Investigación Biomédica en Red de Salud Mental) ;
Pélaez, T. (Centro de Investigación Biomédica en Red de Salud Mental) ;
Barrigón, M. L. (Area de Gestión Sanitaria Sur Granada, Motril) ;
González-Higueras, F. (Complejo Hospitalario de Jaén) ;
Ruiz-Delgado, I. (Unidad de Salud Mental Comunitaria Málaga Norte) ;
Cid, J. (Institut d'Assistencia Sanitària, Girona) ;
Moritz, S. (University Medical Center Hamburg) ;
Ochoa, Susana (Centro de Investigación Biomédica en Red de Salud Mental) ;
Universitat Autònoma de Barcelona
2022 - 10.1038/s41537-021-00199-4
NPJ Schizophrenia, Vol. 8 (february 2022)
|
|
4.
|
12 p, 926.4 KB |
Consensus of experts from the Spanish Pharmacogenetics and Pharmacogenomics Society and the Spanish Society of Medical Oncology for the genotyping of DPYD in cancer patients who are candidates for treatment with fluoropyrimidines
/
García-Alfonso, Pilar (Hospital General Universitario Gregorio Marañón) ;
Saiz-Rodríguez, M. (Hospital Universitario de Burgos) ;
Mondéjar, R. (Hospital Universitario de la Princesa (Madrid)) ;
Salazar, Juliana (Institut d'Investigació Biomèdica Sant Pau) ;
Páez, David (Institut d'Investigació Biomèdica Sant Pau) ;
Borobia, A. M. (Hospital Universitario La Paz (Madrid)) ;
Safont, M. J. (Universitat de València) ;
García-García, I. (Hospital Universitario La Paz (Madrid)) ;
Colomer, R. (Hospital Universitario de la Princesa (Madrid)) ;
García-González, X. (Hospital General Universitario Gregorio Marañón) ;
Herrero, M. J. (Universitat de València) ;
López-Fernández, L. A. (Hospital General Universitario Gregorio Marañón) ;
Abad-Santos, F. (Hospital Universitario de la Princesa (Madrid)) ;
Universitat Autònoma de Barcelona
5-Fluorouracil (5-FU) and oral fluoropyrimidines, such as capecitabine, are widely used in the treatment of cancer, especially gastrointestinal tumors and breast cancer, but their administration can produce serious and even lethal toxicity. [...]
2021 - 10.1007/s12094-021-02708-4
Clinical & Translational Oncology, Vol. 24 (november 2021) , p. 483-494
|
|
5.
|
9 p, 1.8 MB |
Virtual simulation of the biomechanics of the abdominal wall with different stoma locations
/
Tuset, Lluís (Universitat Rovira i Virgili) ;
López-Cano, Manuel (Hospital Universitari Vall d'Hebron) ;
Fortuny, Gerard (Universitat Rovira i Virgili) ;
López, Josep M. (Universitat Rovira i Virgili) ;
Herrero, Joan (Universitat Rovira i Virgili) ;
Puigjaner, Dolors (Universitat Rovira i Virgili) ;
Universitat Autònoma de Barcelona
An ostomy is a surgical procedure by which an artificial opening in the abdominal wall, known as a stoma, is created. We assess the effects of stoma location on the abdominal wall mechanics. We perform three-dimensional finite element simulations on an anatomy model which was generated on the basis of medical images. [...]
2022 - 10.1038/s41598-022-07555-z
Scientific reports (Nature Publishing Group), Vol. 12 (march 2022)
|
|
6.
|
10 p, 4.0 MB |
Eculizumab discontinuation in atypical haemolytic uraemic syndrome : TMA recurrence risk and renal outcomes
/
Ariceta, Gema (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Fakhouri, Fadi (CHU de Nantes) ;
Sartz, Lisa (Skane University Hospital) ;
Miller, Benjamin (Alexion Pharmaceutical (Estats Units d'Amèrica)) ;
Nikolaou, Vasilis (Parexel International (Regne Unit)) ;
Cohen, David (Columbia University Medical Center) ;
Siedlecki, Andrew M (Brigham and Women's Hospital) ;
Ardissino, Gianluigi (Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico) ;
Universitat Autònoma de Barcelona
Eculizumab modifies the course of disease in patients with atypical haemolytic uraemic syndrome (aHUS), but data evaluating whether eculizumab discontinuation is safe are limited. Patients enrolled in the Global aHUS Registry who received ≥1 month of eculizumab before discontinuing, demonstrated haematologic or renal response prior to discontinuation and had ≥6 months of follow-up were analysed. [...]
2021 - 10.1093/ckj/sfab005
Clinical Kidney Journal, Vol. 14 (january 2021) , p. 2075-2084
|
|
7.
|
15 p, 1.9 MB |
Growth and CD4 patterns of adolescents living with perinatally acquired HIV worldwide, a CIPHER cohort collaboration analysis
/
Jesson, Julie (Université Paul Sabatier Toulouse 3) ;
Crichton, Siobhan (University College London. MRC Clinical Trials Unit) ;
Quartagno, Matteo (University College London. MRC Clinical Trials Unit) ;
Yotebieng, Marcel (Albert Einstein College of Medicine. Department of Medicine. Division of General Internal Medicine) ;
Abrams, Elaine J. (Columbia University. Mailman School of Public Health. ICAP at Columbia University) ;
Chokephaibulkit, Kulkanya (Mahidol University. Faculty of Medicine Siriraj Hospital. Siriraj Institute of Clinical Research) ;
Le Coeur, Sophie (Chiang Mai University. Faculty of Associated Medical Sciences. UMI-174/PHPT. Institut de Recherche pour le Developpement (IRD)) ;
Aké-Assi, Marie-Hélène (University Hospital Yopougon) ;
Patel, Kunjal (Harvard T. H. Chan School of Public Health) ;
Pinto, Jorge (Federal University of Minas Gerais. School of Medicine) ;
Paul, Mary (Texas Children's Hospital-USA. Baylor International Pediatric AIDS Initiative) ;
Vreeman, Rachel (Icahn School of Medicine at Mount Sinai) ;
Davies, Mary-Ann (University of Cape Town. Faculty of Health Sciences. School of Public Health and Family Medicine) ;
Ben-Farhat, Jihane (Médecins Sans Frontières. Epicentre) ;
Van Dyke, Russell (Tulane University Health Sciences Center) ;
Judd, Ali (University College London. MRC Clinical Trials Unit) ;
Mofenson, Lynne (Elizabeth Glaser Pediatric AIDS Foundation) ;
Vicari, Marissa (International AIDS Society) ;
Seage, George (University Hospital Yopougon) ;
Bekker, Linda-Gail (University of Cape Town. Desmond Tutu HIV Centre) ;
Essajee, Shaffiq (UNICEF) ;
Gibb, Diana (University College London. MRC Clinical Trials Unit) ;
Penazzato, Martina (World Health Organization) ;
Collins, Intira Jeannie (University College London. MRC Clinical Trials Unit) ;
Wools-Kaloustian, Kara (Indiana University School of Medicine) ;
Slogrove, Amy (Stellenbosch University. Faculty of Medicine & Health Sciences) ;
Powis, Kate (University Hospital Yopougon) ;
Williams, Paige (University Hospital Yopougon) ;
Matshaba, Mogomotsi (Baylor College of Medicine Children's Foundation) ;
Thahane, Lineo (Baylor College of Medicine Children's Foundation) ;
Nyasulu, Phoebe (Baylor College of Medicine Children's Foundation) ;
Lukhele, Bhekumusa (Baylor College of Medicine Children's Foundation) ;
Mwita, Lumumba (Baylor College of Medicine Children's Foundation) ;
Kekitiinwa-Rukyalekere, Adeodata (Baylor College of Medicine Children's Foundation) ;
Wanless, Sebastian (Federal University of Minas Gerais. School of Medicine) ;
Goetghebuer, Tessa (Hospital St Pierre) ;
Thorne, Claire (University College London. UCL Great Ormond Street Institute of Child Health) ;
Warszawski, Josiane (Centre de recherche en Epidémiologie et Santé des Populations. Inserm U1018) ;
Galli, Luisa (University of Florence) ;
van Rossum, Annemarie M.C (Erasmus MC University Medical Center Rotterdam-Sophia Children's Hospital) ;
Giaquinto, Carlo (Padova University/PENTA Foundation) ;
Marczynska, Magdalena (Hospital of Infectious Diseases in Warsaw. Medical University of Warsaw) ;
Marques, Laura (Centro Hospitalar do Porto) ;
Prata, Filipa (Hospital de Santa Maria) ;
Ene, Luminita (Victor Babes Hospital) ;
Okhonskaya, Lyuba (Republican Hospital of Infectious Diseases) ;
Navarro, Marisa (Hospital General Universitario Gregorio Marañón) ;
Frick, Antoinette (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Naver, Lars (Karolinska University Hospital and Karolinska, Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Kahlert, Christian (Children's Hospital of Eastern Switzerland) ;
Volokha, Alla (Shupyk National Medical Academy of Postgraduate Education) ;
Chappell, Elizabeth (University College London. MRC Clinical Trials Unit) ;
Pape, Jean William (GHESKIO Center) ;
Rouzier, Vanessa (GHESKIO Center) ;
Marcelin, Adias (GHESKIO Center) ;
Succi, Regina (Sao Paulo. Universidade Federal de Sao Paulo) ;
Sohn, Annette H. (TREAT Asia/amfAR) ;
Kariminia, Azar (University of New South Wales. Kirby Institute) ;
Edmonds, Andrew (University of North Carolina at Chapel Hill. Gillings School of Global Public Health) ;
Lelo, Patricia (Pediatric Hospital Kalembe Lembe) ;
Lyamuya, Rita (Morogoro Regional Hospital) ;
Ogalo, Edith Apondi (Moi Teaching and Referral Hospital) ;
Odhiambo, Francesca Akoth (Kenya Medical Research Institute) ;
Haas, Andreas D. (University of Bern. Institute of Social and Preventive Medicine) ;
Bolton, Carolyn (Centre for Infectious Disease Research in Zambia) ;
Muhairwe, Josephine (SolidarMed) ;
Tweya, Hannock (Lighthouse Trust Clinic) ;
Sylla, Mariam (CHU Gabriel Toure) ;
D'Almeida, Marceline (Centre National Hospitalier Universitaire Hubert K. Maga) ;
Renner, Lorna (Korle-Bu Teaching Hospital (Ghana)) ;
Abzug, Mark J. (University of Colorado School of Medicine and Children's Hospital Colorado) ;
Oleske, James (Rutgers - New Jersey Medical School) ;
Purswani, Murli (Bronx-Lebanon Hospital Center) ;
Teasdale, Chloe (Columbia University. Mailman School of Public Health. ICAP at Columbia University) ;
Nuwagaba-Biribonwoha, Harriet (Columbia University. Mailman School of Public Health. ICAP at Columbia University) ;
Goodall, Ruth (University College London. MRC Clinical Trials Unit) ;
Leroy, Valériane (Université Paul Sabatier Toulouse 3. Inserm) ;
Universitat Autònoma de Barcelona
Adolescents living with HIV are subject to multiple co-morbidities, including growth retardation and immunodeficiency. We describe growth and CD4 evolution during adolescence using data from the Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) global project. [...]
2022 - 10.1002/jia2.25871
Journal of the International AIDS Society, Vol. 25 (march 2022)
|
|
8.
|
12 p, 884.6 KB |
Diagnosis of Genetic White Matter Disorders by Singleton Whole-Exome and Genome Sequencing Using Interactome-Driven Prioritization
/
Schlüter, Agatha (Vall d'Hebron University Hospital) ;
Rodríguez-Palmero, Agustí (Hospital Universitari Vall d'Hebron) ;
Verdura, Edgard (Hospital Universitari Vall d'Hebron) ;
Vélez-Santamaría, Valentina (Hospital Universitari Vall d'Hebron) ;
Ruiz, Montserrat (Hospital Universitari Vall d'Hebron) ;
Fourcade, Stéphane (Hospital Universitari Vall d'Hebron) ;
Planas-Serra, Laura (Hospital Universitari Vall d'Hebron) ;
Martínez, Juan José (Hospital Universitari Vall d'Hebron) ;
Guilera, Cristina (Hospital Universitari Vall d'Hebron) ;
Girós, Marisa (Hospital Universitari Vall d'Hebron) ;
Artuch, Rafael (Hospital Universitari Vall d'Hebron) ;
Yoldi, María Eugenia (Hospital Universitari Vall d'Hebron) ;
O'Callaghan, Mar (Hospital Universitari Vall d'Hebron) ;
García-Cazorla, Angels (Hospital Universitari Vall d'Hebron) ;
Armstrong, Judith (Hospital Universitari Vall d'Hebron) ;
Marti, Itxaso (Hospital Universitari Vall d'Hebron) ;
Mondragón Rezola, Elisabet (Hospital Universitari Vall d'Hebron) ;
Redin, Claire (Hospital Universitari Vall d'Hebron) ;
Mandel, Jean Louis (Hospital Universitari Vall d'Hebron) ;
Conejo, David (Hospital Universitari Vall d'Hebron) ;
Sierra-Córcoles, Concepción (Hospital Universitari Vall d'Hebron) ;
Beltrán, Sergi (Hospital Universitari Vall d'Hebron) ;
Gut, Marta (Hospital Universitari Vall d'Hebron) ;
Vázquez, Elida (Hospital Universitari Vall d'Hebron) ;
del Toro, Mireia (Hospital Universitari Vall d'Hebron) ;
Troncoso, Mónica (Hospital Universitari Vall d'Hebron) ;
Pérez-Jurado, Luis A. (Hospital Universitari Vall d'Hebron) ;
Gutiérrez-Solana, Luis G. (Hospital Universitari Vall d'Hebron) ;
López de Munain, Adolfo (Hospital Universitari Vall d'Hebron) ;
Casasnovas, Carlos (Hospital Universitari Vall d'Hebron) ;
Aguilera-Albesa, Sergio (Hospital Universitari Vall d'Hebron) ;
Macaya, Alfons (Hospital Universitari Vall d'Hebron) ;
Pujol, Aurora (Hospital Universitari Vall d'Hebron) ;
Universitat Autònoma de Barcelona
Genetic white matter disorders (GWMD) are of heterogeneous origin, with >100 causal genes identified to date. Classic targeted approaches achieve a molecular diagnosis in only half of all patients. [...]
2022 - 10.1212/WNL.0000000000013278
Neurology, Vol. 98 (march 2022) , p. e912-e923
|
|
9.
|
|
10.
|
10 p, 1.7 MB |
The 2019 and 2021 International Workshops on Alport Syndrome
/
Daga, Sergio (University of Siena) ;
Ding, Jie (Peking University First Hospital) ;
Savige, Judy (The University of Melbourne) ;
Lipska-Ziętkiewicz, Beata S. (Medical University of Gdańsk) ;
Hoefele, Julia (Technical University of Munich) ;
Flinter, Frances (Guys' and St Thomas' NHS Foundation Trust) ;
Gale, Daniel P. (UK Renal Registry. Rare Renal Disease Registry) ;
Aksenova, Marina (Y. Veltischev Research and Clinical Institute for Pediatrics at the Pirogov Russian National Research Medical University) ;
Kai, Hirofumi (Kumamoto University) ;
Perin, Laura (University of Southern California) ;
Barua, Moumita (University of Toronto) ;
Torra Balcells, Roser (Institut d'Investigació Biomèdica Sant Pau) ;
Miner, Jeff H. (Washington University School of Medicine) ;
Massella, Laura (Bambino Gesù Children's Hospital-IRCCS) ;
Ljubanović, Danica Galešić (University of Zagreb) ;
Lennon, Rachel (The University of Manchester) ;
Weinstock, Andrè B. (Alport Syndrome Foundation) ;
Knebelmann, Bertrand (Paris University, Paris, France) ;
Cerkauskaite, Agne (Vilnius University Hospital Santaros Klinikos) ;
Gear, Susie (Alport UK, Tetbury, UK) ;
Gross, Oliver (University Medicine Goettingen) ;
Turner, A. Neil (University of Edinburgh) ;
Baldassarri, Margherita (Azienda Ospedaliero-Universitaria Senese) ;
Pinto, Anna Maria (Azienda Ospedaliero-Universitaria Senese) ;
Renieri, Alessandra (Azienda Ospedaliero-Universitaria Senese) ;
Universitat Autònoma de Barcelona
In 1927 Arthur Cecil Alport, a South African physician, described a British family with an inherited form of kidney disease that affected males more severely than females and was sometimes associated with hearing loss. [...]
2022 - 10.1038/s41431-022-01075-0
European Journal of Human Genetics, march 2022, p. 1-10
|
|